ArticleJournal of neuroinflammation2026
A central role for fibrinogen in promoting microglial repair of the hypoxia-disrupted blood-brain barrier.
Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Use of explainable cluster analysis to identify distinct subtypes of Meige syndrome patients and associated biomarker profiles.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Building on our previous finding that a small fibrinogen peptide inhibits microglial repair of the hypoxia-disrupted blood-brain barrier (BBB), we directly evaluated the importance of fibrinogen in this process by studying these events in fibrinogen knockout (KO) mice. While young (4 months old) fibrinogen KO mice were still capable of mediating a vasculo-protective response to chronic mild hypoxia (CMH; 8% O2), the extent of vascular leak in these mice was much greater than wild-type (WT) mice. Consistent with this, fibrinogen KO mice displayed greatly reduced levels of hypoxia-induced microglial activation, proliferation, and aggregation around leaky blood vessels. Notably, defects in fibrinogen KO mice became more pronounced with age such that by 8-months old, a large fraction (3/8) of fibrinogen KO mice failed to survive 4 days CMH, and those that survived showed much greater loss of myelin and neurons compared to WT. Furthermore, under normoxic conditions, microglia in middle-aged (13 months old) fibrinogen KO mice were significantly less activated compared to WT, suggesting that slow fibrinogen leak across the age-weakened BBB might explain why microglia are more activated in aged mice. Finally, in vitro studies revealed that microglia readily attach to fibrinogen and that compared to other pro-adhesive ECM proteins such as fibronectin, fibrinogen promotes morphological transition into a polarized phenotype capable of greater levels of migration. Together, these observations demonstrate the importance of fibrinogen in promoting an effective microglial vasculo-protective response and suggest that pharmacological manipulation of fibrinogen-microglial interactions in the aged brain could hold therapeutic promise in the prevention or treatment of vascular dementia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.